loratadine has been researched along with Absence Seizure in 2 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A small number of adverse events of seizure in patients using desloratadine (DL) have been reported." | 1.62 | Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015. ( Aas, E; Aasbjerg, K; Bolin, K; Born, AP; Brady, JE; Emneus, M; Ersbøll, AK; Gislason, G; Kjærulff, TM; Mines, D; Pukkala, E; Ramey, DR; Sengupta, K; Vestergaard, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ersbøll, AK | 1 |
| Sengupta, K | 1 |
| Pukkala, E | 1 |
| Bolin, K | 1 |
| Aas, E | 1 |
| Emneus, M | 1 |
| Ramey, DR | 1 |
| Brady, JE | 1 |
| Mines, D | 1 |
| Aasbjerg, K | 1 |
| Vestergaard, C | 1 |
| Gislason, G | 1 |
| Born, AP | 1 |
| Kjærulff, TM | 1 |
| Iorio, LC | 1 |
| Cohen-Winston, M | 1 |
| Barnett, A | 1 |
2 other studies available for loratadine and Absence Seizure
| Article | Year |
|---|---|
Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015.
Topics: Adult; Child; Cohort Studies; Female; Humans; Incidence; Loratadine; Male; Research Design; Seizures | 2021 |
Interaction studies in mice of SCH 29851, a potential non-sedating antihistamine, with commonly used therapeutic agents.
Topics: Animals; Benzhydryl Compounds; Diphenhydramine; Dose-Response Relationship, Drug; Electroshock; Hexo | 1986 |